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What Is Carrion’s Disease?: The Forgotten
Carrion’s disease is a biphasic illness (S1 Fig) caused by an infection of Bartonella bacilliformis,
a bacterium that is transmitted through bites of certain phlebotomine sand flies in the Andean
valleys of Peru and in some areas of Ecuador and southern Colombia [1,2]. The acute phase,
calledOroya fever, is a serious, life-threating illness that mainly affects immunologically naïve
populations, such as children. It is also of special concern in pregnant women, because high
mortality rates have been described as well as miscarriages, preterm births, and fetal deaths [3].
In this acute phase, the absence or delay of antibiotic treatment may lead to fatal outcomes. In
fact, it is considered that, in the pre-antibiotic era, the lethality of this illness ranked between
40% and 88% [1,2]. In the chronic phase, classically considered to occur in previously exposed
inhabitants, B. bacilliformis induce endothelial cell proliferation, producing skin lesions called
Peruvian warts. In this phase, the lethality is very low [1]. Additionally, the presence of asymp-
tomatic carriers is frequent, although the real numbers remain uncertain because of the diffi-
culty in detecting these subjects (Table 1) [4].
Until now, no reservoir other than humans has ever been described, and, thus, due to the
geographically defined area and the lack of animal reservoirs, this disease could be potentially
eradicated.
The role of undescribedBartonella spp. as a cause of Carrion’s-disease–like symptoms can-
not be ruled out. Indeed, other Bartonella spp. have correlated to Carrion’s-disease–like pre-
sentations. Thus, Bartonella rochalimae, which is disseminated worldwide [5], was associated
with a mild Oroya-fever–like episode in a tourist after a trip to Peru, whereas Bartonella anca-
shensis has been isolated from Peruvian warts of children living in an endemic Peruvian area
[1].
Despite vector transmission being by far the most relevant route of transmission, other pos-
sible routes should be highlighted.Due to the nature of the illness, all direct inoculation or con-
tact with infected human bloodmay result in its acquisition; thus, blood transfusions as well as
accidental contact with infected blood in laboratories or duringmedical practices need to be
considered. Additionally, vertical transmission and contact with other human fluids should
also be considered (Fig 1).
Vector Transmission of B. bacilliformis: The Story Always Told
Native inhabitants traditionally considered sand flies as causing Carrion’s disease, and, in the
middle of the 18th century, Cosme Bueno proposed their role as vectors of Carrion’s disease
and Leishmania [7]. Nonetheless, the vector role of Lutzomyia verrucarum in the illness was
PLOS Pathogens | DOI:10.1371/journal.ppat.1005863 October 13, 2016 1 / 6
a11111
OPENACCESS
Citation: Pons MJ, Gomes C, del Valle-Mendoza J,
Ruiz J (2016) Carrion’s Disease: More Than a Sand
Fly–Vectored Illness. PLoS Pathog 12(10):
e1005863. doi:10.1371/journal.ppat.1005863
Editor: Kimberly A. Kline, Nanyang Technological
University, SINGAPORE
Published: October 13, 2016
Copyright: © 2016 Pons et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Funding: This study has been funded by the
Programa Nacional de Innovacio´n para la
Competitividad y Productividad (Inno´vate Peru´)
under the contract 117-PNICP-PIAP-2015. JR has
a fellowship from the program I3, of the ISCIII
[grant number: CES11/012]. CG has a PhD
fellowship of the ISCIII (FI12/00561). The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
not confirmed until 1913, more than 40 years after the devastating Carrion’s disease episode in
1870–1871 that occurredduring the construction of the Lima-LaOroya railway, causing sev-
eral thousands of deaths [1,8].
B. bacilliformis is naturally transmitted by sand flies belonging to the Lutzomyia genus,
mainly L. verrucarum, but also Lutzomyia peruensis [1,2]. However, the illness is also present
in areas where these vectors are absent, suggesting the presence of undescribedvectors, or the
undetected established vectors of B. bacilliformis [1]. In fact, the vector role of L. peruensiswas
described after an outbreak in an L. verrucarum-free area [1].
Vector sand flies are present in the inter-Andean valleys between 400 and 3,200 m [1,2].
Nonetheless, since the late 1990s, a continuous expansion of the illness to previously considered
free areas, including coastal and high jungle areas, has been evident. It has been associatedwith
the current situation of climate change, which, together with human activities, is presumably
affecting the vector distribution, leading to vector expansion [1]. Additionally, the El Niño phe-
nomenon results in increasing humidity levels, favoring sand fly reproduction and facilitating the
development of Carrion’s disease outbreaks [1]. Moreover, the potential of Lutzomyia spp. living
in non-endemic areas to become adapted as vectors of B. bacilliformis should not be ruled out.
Blood Transfusion: The Hidden Risk
Similar to other Bartonella species [9], B. bacilliformis is able to survive a long time in infected
blood at 4°C [10,11]. In 1926, Noguchi reported that B. bacilliformis can survive 152 days in
experimentally infectedmonkey blood samples stored at 4°C [10]. More recently, viable B.
bacilliformis was recovered fromOroya fever patients’ blood stored at 4°C for as long as 30
months [11]. It has been considered that infections with B. bacilliformis occur in populations
Table 1. Main facts on Carrion’s disease.
Facts1 Oroya fever Asymptomatic carrier Peruvian wart
Symptoms and Signs Abdominal pain Arthralgia
Anorexia/Hiporexia Bone pain
Arthralgia Fever
" Bilirubin Headache
Chills 1 Joint pain
Diarrhea Lymphadenopathy
Dyspnea Malaise
Fever (up to 99%) 2 Myalgia
Headache Skin lesions
# Hematocrit (up to >80%)
Hemolytic Anemia (up to >90%) 3
Hepatomegaly
Hypothermia
Jaundice
Lymphadenopathy
Malaise
Myalgia
Nausea/Vomiting
Pallor
Pollakiuria
" Protein C Reactive
Splenomegaly
Sweats
Systolic murmur
Tachycardia
(Continued)
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Table 1. (Continued)
Facts1 Oroya fever Asymptomatic carrier Peruvian wart
Complications Immunosuppression Bleeding
Co-infections4 Dermal infection
bloodstream Salmonella Necrosis
bloodstream S. aureus
Leptospirosis
Latent infections4
Histoplasmosis
Toxoplasmosis
Tuberculosis
Cardiovascular
Anasarca
Cardiovascular shock
Congestive heart failure
Myocarditis
Pericardial effusion
Pericardial tamponade
Gastrointestinal
Digestive hemorrhage
Gyneco-obstetrics
Fetal death
Miscarriages
Pre-term births
Hepatical
Acute cholecystitis
Hepatocellular necrosis.
Neurological
Altered Mental Status
Increased intracranial pressure
Coma
Convulsion
Respiratory
Acute Pulmonary Edema
Other
Purpura
Renal insufficiency
Treatment Blood Transfusions Amoxicillin plus clavulanic acid5 Erythromycin, Azithromycin
Amoxicillin plus clavulanic acid5 Ciprofloxacin Rifampicin
Chloramphenicol ± other antibiotics
Ciprofloxacin ± Cephalosporin
Outcome Development of partial immunity6 Perpetuators of the illness Development of partial immunity
Lack of bacterial clearance6 Potential infected blood/organ donations Lack of bacterial clearance
Vertical transmission risk Vertical transmission risk Vertical transmission risk
Death7
In bold, the more frequent and/or relevant signs and symptoms, as well as complications. Orange shaded, complications that more often result in a fatal
outcome.
1 Nonexhaustive list.
2 Moderate (usually less than 39˚C) and intermittent.
3 With negative Coombs test.
4 Listed some of the most commonly detected.
5 Mainly in pregnant women.
6 Uncertain number due to the low blood bacterial burden and the lack of sensitive diagnostic tools. It has been reported that 45% of inhabitants from an
endemic area have antibodies against B. bacilliformis [2].
7 If correctly treated, case fatality rates ranks from 0.5%–1% in peripheral health centers and 8%–10% in reference centers (because of the reception of
complicated cases); when not treated, case fatality ranks between 40% and 88%. In any case, it is especially relevant among children and pregnant women.
doi:10.1371/journal.ppat.1005863.t001
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unlikely to be qualified as blood donors [12]. Nonetheless, the slow bacterial growth, the inabil-
ity of definitive diagnostic approaches to consistently detect carriers [4], and the undefined
duration of the asymptomatic carrier status, which may be up three years [13], are clear risks
that may result in posttransfusion infections.Moreover, this risk, which is not limited to
endemic regions, may extend to other areas due to the migration phenomena from rural to
urban areas and low- or middle- to high-income countries.
In endemic zones, blood banks perform blood smears to detect the presence of B. bacillifor-
mis, while in neighboring regions, blood donations of persons living in endemic areas are not
accepted [14]. In blood banks from other regions or countries, no specificmeasures are taken
to determine the presence of B. bacilliformis. Nonetheless, confirmed or suspected cases of
post-transfusionCarrion’s disease are scarce. This may be due to the low-income nature of the
main regions affected, which results in a low number of cases being reported, as well as a high
number of previously exposed inhabitants, of up to 45% [2], who have developed partial immu-
nity that may prevent or minimize the effect of transfusion-mediated transmission. In fact, ear-
lier 20th century reports considered that almost all local inhabitants had partial immunity [8].
Moreover, most data on Carrion’s disease are only reported at a local level, thereby contribut-
ing to lack of disease visibility at an international level.
From the few reports present in the literature, two are strongly suggestive of transfusion
transmission. In 1972, a newborndied fromOroya fever after a blood transfusion in a B. bacilli-
formis-endemic area. In this case, vertical transmission was not considered, as the mother did
not have a previous Bartonella infection [15]. More recently, the acquisition of Oroya fever has
been described in a chronic myeloid leukemia patient receivingmultiple blood and platelet
transfusions, one of which was contaminated with B. bacilliformis [14].
The possibility of B. bacilliformis transmission during organ transplantation is also plausi-
ble. Indeed, posttransplant infectionwith a Bartonellaceae (Bartonella henselae) has been pro-
posed [16].
Fig 1. B. bacilliformis transmission routes. 1 Humans are the only known reservoir. 2 Despite a report by
Noguchi et al [6], no confirmatory result has been published.
doi:10.1371/journal.ppat.1005863.g001
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Vertical Transmission: The Nightmare
Vertical transmission was first proposed in 1858 by Tomas de Salazar [15]. Similarly, in 1913,
Strong et al stated “We saw cases in young nursing children, and Campodonico and Monge
state it occurs in newly born infants,” again suggesting the presence of vertical transmission
[8]. Subsequently, bothMalpartida and Colareta proposed the same in the mid-1930s [15].
Nonetheless, unequivocal reports in the recent literature are scarce. In addition to the rea-
sons for the low number of reports of transfusion transmission, the serious consequences of
the acute phase of Carrion’s disease during pregnancy should also be considered, especially
when the infection occurs in the first months of pregnancy, affecting both the mother with seri-
ous complications and high lethality for the fetus, including preterm births, miscarriages, or
fetal deaths, among others [3,15]. Additionally, social attitudes and traditional practicesmay
lead to delays or nonuse of health centers during pregnancy or after child birth [17], resulting
in underestimation or misdiagnosis of mother-to-child B. bacilliformis transmissions, which
thus may be higher than considered.
In 2003, it was reported that blood samples collected from a preterm child, 90 minutes after
birth, of a mother with verrucous lesions, resulted in B. bacilliformis-positive culture [15]. In
1994, a neonate (19 days) was reported with Oroya fever, in whom 30% of the red blood cells
were infected, thereby implicating the mother with general malaise, and diagnosedwith a posi-
tive blood smear [18]. Finally, in 2015, another case was reported in which a 22-day-old child
of a mother with a Peruvian wart was admitted with Oroya fever [19].
Intentional or Accidental Inoculation with Fluids or Blood: Heroes,
Crazies, and Unfortunates
Inoculation with contaminated body fluids is a direct way to acquire Carrion’s disease.
Although currently direct human inoculations with infected human fluids are limited to acci-
dents, in the last years of the 19th and in the early 20th centuries, experiments inoculating vol-
unteers with either infected blood or wart exudates were performed. The most classical
example is the self-inoculationof Daniel Alcides Carrión in 1885. He inoculated himself with a
wart exudate and developedOroya fever with a fatal outcome [20]. Subsequently, in 1928, Gar-
cia Rosell received an accidental inoculation from the contaminated blood of a patient with
Oroya fever and developed a febrile illness that was cured, followed by eruption of Peruvian
warts [20].
Conclusion: Risks and Opportunities
Although Carrion’s disease is currently restricted to specific geographical zones, increasing
tourism to endemic regions together with continuous human migratory processes may lead to
both imported cases and presence of asymptomatic carriers outside of traditional areas, driving
towards establishment of non-vectorialB. bacilliformis mother-to-child transmission or
through blood transfusions. Those, along with the incessant and growing movement of goods,
may also facilitate the accidental introduction of vectors into atypical habitats. These findings
highlight the risk of B. bacilliformis transmission beyond traditionally affected regions and
reinforce the need to develop a Carrion’s disease eradication agenda.
Supporting Information
S1 Fig. B. bacilliformismay infect three different populations: healthy never exposed,
healthy pre-exposed,or asymptomatic carriers (the infection of personswith either active
Oroya fever or Peruvian wart is not considered, because these people should be under
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treatment).The illness evolution may vary leading to Oroya fever, Peruvian wart, or asymp-
tomatic infectionwith different easiness. Moreover, although no data are available, the natural
bacteria clearance may not be ruled out. Although not to scale, the arrows’ size represents the
probability of infection evolution.? 1 No data about.
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